Methylenetetrahydrofolate Reductase (MTHFR) gene polymorphism and migraine

Journal of Child Neurology

Volumn 27, Issue 4, 2012, Pages 544-

  Gómez Lado, Carmen ^a   Pérez Gay, Laura ^a   Eirís Puñal, Jesús ^a   Castro Gago, Manuel ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MIGRAINE; NOTE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CEREBROVASCULAR DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PEDIATRICS; POLYMORPHISM, GENETIC;

EID: 84859338718     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811421828     Document Type: Note

References (4)

1. Alsayouf H, Zamel KM, Heyer GL, Khuhro AL, Kahawash SB, de los Reyes EC. Role of methylenetetrahydrofolate reductase gene (MTHFR) 677C>T polymorphism in pediatric cerebrovascular disorders. J Child Neurol. 2011;26:318-321.
2. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiyhs LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004;2:3.
3. Oterino A, Valle N, Bravo Y, et al. MTHFR T677 homozygosis influences the presence of aura in migraine. Cephalalgia. 2004;24:491-494. (Pubitemid 38748031)
4. Di Rosa G, Attiná S, Sparó M, et al. Efficacy of folic acid in children with migraine, hyperhomocysteinemia and MTHFR polymorphisms. Headache. 2007;47:1342-1344. (Pubitemid 47561535)